06/06/2026
If you are a woman between the ages of 35 and 42 who has been
diagnosed with infertility (difficulty becoming pregnant), with
regular menstrual cycles (every 21-35 days), you may be eligible for
participation in this study.
This national Phase III clinical study is designed to test a new medication used during IVF treatment, with our own Dr. John Park as the Principal Investigator!
Eligible participants may receive up to two IVF cycles at no cost, including:
✨ PGT-A
✨ Medications
✨ Frozen embryo transfer (FET)
If you’d like to learn more or be considered for enrollment, please book a consultation or appointment to meet with a physician. We will review your history, discuss your treatment goals, and determine whether the study may be a good fit for you.
If you have additional questions about this study, please reach out to [email protected].